Dr. Richard Furman Describes Diffuse Large B-Cell Lymphoma Treatment Regimens

In this Onc Live video, Dr. Richard Furman, Director of the CLL Research Center describes the chemotherapy regimens available to patients with diffuse large B-cell lymphoma. (DLBCL)

A list of DLBCL trials at Weill Cornell Medicine is available on the Joint Clinical Trials website.

Author: lymphomaprogram

Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.

Post a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: